Aberrant Expression of CD56 in Patients With Hematologic Malignancies.

Clinical trial NCT04546945 · RECRUITING

Trial details

NCT number: NCT04546945
Sponsor: Asmaa Hassan mohamed Abdel Mawjoud
Status: RECRUITING
Study type: OBSERVATIONAL

Hematologic Malignancies

Start date: 2027-03-20
Primary completion: 2027-06-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.